Our Vision
Restoring vision with a new class of regenerative cell therapies.
-
Transplant tissues are mainly procured from deceased donors
-
Grafts suffer from variable quality
& limited supply -
Patients throughout the world need expanded treatment options
-
Laboratory cultured cells can ensure high quality with an improved safety profile
-
Cultured cells expand the supply of tissue, expanding access to quality care
-
OcuCell technologies address both common and orphan diseases
Ocular Cell Therapy: From Dream to Reality
Cell therapies are poised for adoption:
-
High unmet need in multiple disease areas
-
Regulatory pathways are being established
-
Cell-based treatments are ready to enter the clinic
Benefits of cultivated cells:
​
-
Increased access to transplant tissue
-
Improved quality & consistency
-
Enhanced safety testing
OcuCell co-founders, advisors, and investors bring with them:
​
-
Expertise in cell therapy, materials science, and transplant surgery
-
Specialized industry knowledge
-
Strategic distribution partnerships
